Electrophysiological characterization of tight junctional pathway of rabbit cornea treated with ophthalmic ingredients

Biological and Pharmaceutical Bulletin

Volumn 30, Issue 12, 2007, Pages 2360-2364

  Nakamura, Tadahiro ^a   Yamada, Mikiko ^b   Teshima, Mugen ^a   Nakashima, Mikiro ^b   To, Hideto ^a   Ichikawa, Nobuhiro ^a   Sasaki, Hitoshi ^a  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

Author keywords

Cornea; Electrophysiolosy; Eye; Permeability; Tight junction

Indexed keywords

BENZALKONIUM CHLORIDE; DECANOIC ACID; DODECYL SULFATE SODIUM; EDETIC ACID; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; SAPONIN; TAUROCHOLIC ACID;

ANIMAL TISSUE; ARTICLE; CONDUCTANCE; CORNEA; CYTOTOXICITY; ELECTRIC RESISTANCE; ELECTROPHYSIOLOGY; NONHUMAN; TIGHT JUNCTION; TOXICITY;

ABSORPTION; ANIMALS; CELL MEMBRANE PERMEABILITY; CELL SURVIVAL; CORNEA; DATA INTERPRETATION, STATISTICAL; DEXTRANS; DIFFUSION CHAMBERS, CULTURE; ELECTROPHYSIOLOGY; FLUORESCEIN-5-ISOTHIOCYANATE; MALE; OPHTHALMIC SOLUTIONS; RABBITS; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS;

EID: 36849010158     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.30.2360     Document Type: Article

References (29)

1. Burstein N. L., Klyce S. D., Invest. Ophthalmol. Vis. Sci., 16, 899-911 (1977).
2. Salama N. N., Eddington N. D., Fasano A., Adv. Drug Deliv. Rev., 58, 15-28 (2006).
3. Marsh R. J., Maurice D. M., Exp. Eye Res., 11, 43-48 (1971).
4. Smolen V. F., Clevenger J. M., Williams E. J., Bergdolt M. W., J. Pharm. Sci., 62, 958-961 (1973).
5. Newton C., Gebhardt B. M., Kaufman H. E., Invest. Ophthalmol. Vis. Sci., 29, 208-215 (1988).
6. Sasaki H., Tei C., Yamamura K., Nishida K., Nakamura J., J. Pharm. Pharmacol., 46, 871-875 (1994).
7. Sasaki H., Yamamura K., Tei C., Nishida K., Nakamura J., J. Drug Target., 3, 129-135 (1995).
8. Schoenwald R. D., Huang H.-S., J. Pharm. Sci., 72, 1266-1272 (1983).
9. Klyce S. D., Crosson C. E., Curr. Eye Res., 4, 323-331 (1985).
10. Hayashi M., Xenobio. Metab. Dispos., 7, 621-631 (1992).
11. Mathers W. D., Sherman M., Fryczkowski A., Jester J. V., Invest. Ophthalmol. Vis. Sci., 30, 2403-2406 (1989).
12. Phan T. M., Foster C. S., Zagachin L. M., Colvin R. B., Invest. Ophthalmol. Vis. Sci., 30, 386-391 (1989).
13. Harris D., Liaw J. H., Robinson J. R., Adv. Drug Del. Rev., 8, 331-339 (1992).
14. Horibe Y., Hosoya K., Kim K. J., Ogiso T., Lee V. H., Pharm. Res., 14, 1246-1251 (1997).
15. Sasaki H., Nagano T., Yamamura K., Nishida K., Nakamura J., J. Pharm. Pharmacol., 47, 703-707 (1995).
16. Rojanasakul Y., Wang L. Y., Bhat M., Glover D. D., Malanga C. J., Ma J. K., Pharm. Res., 9, 1029-1034 (1992).
17. Ashton P., Diepold R., Platzer A., Lee V. H., J. Ocul. Pharmacol., 6, 37-42 (1990).
18. Hochman J., Artursson P., J. Control. Release, 29, 253-267 (1994).
19. Tomita M., Hayashi M., Awazu S., Biol. Pharm. Bull., 17, 753-755 (1994).
20. Tomita M., Hayashi M., Awazu S., J. Pharm. Sci., 85, 608-611 (1996).
21. Kawashima Y., "Ophthalmology Practice," Vol. 42, ed. by Honda K., Bunkodo, Japan, 1999, pp. 76-79.
22. Takahashi H., Shibasaki T., Takeshita K., Kaiho F., Hayashi M., Biol. Pharm. Bull., 20, 446-448 (1997).
23. Lindmark T., Kimura Y., Artursson P., J. Pharmacol. Exp. Ther., 284, 362-369 (1998).
24. Hayashi M., Sakai T., Hasegawa Y., Nishikawahara T., Tomioka H., Iida A., Shimizu N., Tomita M., Awazu S., J. Control. Release, 62, 141-148 (1999).
25. Imai T., Sakai M., Ohtake H., Azuma H., Otagiri M., Int. J. Pharm., 294, 11-21 (2005).
26. Hersey S. J., Jackson R. T., J. Pharm. Sci., 76, 876-879 (1987).
27. Sharma P., Varma M. V., Chawla H. P., Panchagnula R., Farmaco, 60, 884-893 (2005).
28. Yamamoto A., Uchiyama T., Nishikawa R., Fujita T., Muranishi S., J. Pharm. Pharmacol., 48, 1285-1289 (1996).
29. Gordon G. S., Moses A. C., Silver R. D., Flier J. S., Carey M. C., Proc. Natl. Acad. Sci. U.S.A., 82, 7419-7423 (1985).